Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Bimatoprost is effective for growing longer, thicker, and darker eyelashes.

A man with a rare scalp cancer was successfully treated, highlighting the need for early management to prevent spread and complications.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

EGFR inhibitors can cause yellowish skin eruptions.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Lasers can help reduce skin side effects from cancer treatment.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Cetuximab can cause eyelash growth, which is rare but manageable.

Understanding hair growth involves complex interactions between molecules and could help treat hair disorders.

Targeted cancer therapies often cause serious skin problems that need careful management.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.